SCHEMBL12496006

SCHEMBL12496006

CCCCc1c(Cl)nc(N)nc1-c1ccoc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 5/20 0.48
▸ ADORA1 P30542 4/20 0.42
▸ HTR1A P08908 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR7 P34969 1/20 0.38
▸ HTR6 P50406 1/20 0.38
▸ TLR7 Q9NYK1 2/20 0.37
▸ TLR8 Q9NR97 4/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ PLAU P00749 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ PIK3CA P42336 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ RICTOR Q6R327 1/20 0.33
▸ RPTOR Q8N122 1/20 0.33
▸ MAPKAP1 Q9BPZ7 1/20 0.33
▸ MLST8 Q9BVC4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21313181 0.90 ADORA2A (0.54) ADORA2AADORA1HTR1ADRD2HTR2A
SCHEMBL12495875 0.84 ADORA2A (0.58) ADORA2AADORA1HTR1ADRD2HTR2A
SCHEMBL21313222 0.83 ADORA2A (0.47) ADORA2AADORA1HTR1ADRD2HTR2A
SCHEMBL21313268 0.82 ADORA2A (0.46) ADORA2AADORA1HTR1ADRD2HTR2A
SCHEMBL12495995 0.80 HEXA (0.48) ADORA2AADORA1HTR1AHTR2ATLR8
SCHEMBL12495846 0.80 TLR8 (0.54) ADORA2AADORA1TLR7TLR8SMN1; SMN2
SCHEMBL21313164 0.80 HRH3 (0.52) ADORA2AADORA1TLR8HRH2HRH3
SCHEMBL12495903 0.80 ADORA2A (0.44) ADORA2AADORA1HTR1ADRD2HTR2A
SCHEMBL21313215 0.80 ADORA2A (0.47) ADORA2AADORA1SMN1; SMN2KDM4EHPGD
SCHEMBL12496008 0.79 GCGR (0.43) ADORA2AADORA1TLR7TLR8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3195867-A1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF Ustav Organicke Chemie A Biochemie Akademie Ved Cr, v.v.i. (CZ) 2017-07-26 — — EP disclosed
US-8883798-B2 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2014-11-11 — — US disclosed
US-8883798-B2 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2014-11-11 — — US disclosed
EP-2680847-A1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF Ustav Organicke Chemie A Biochemie Akademie Ved Cr, v.v.i. (CZ) 2014-01-08 — — EP disclosed
WO-2012116666-A1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2012-09-07 — — WO disclosed
Send feedback